Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 174   

Articles published

GSK 1,415.50 +3.50 (0.25%)
price chart
GlaxoSmithKline plc Shares Up After Earnings
GlaxoSmithKline plc (ADR) (NYSE:GSK) (LON:GSK) released the earnings results from its most recently completed quarter this morning, posting core earnings of 27.9 pence per share, excluding divestments.
GlaxoSmithKline plc Jumps After Beating City Expectations  The Motley Fool UK
UPDATE: Glaxo Launches Restructuring As Sliding Advair Sales Hit Profit  London South East
Related articles »  
2 Numbers That Could Make GlaxoSmithKline plc A Spectacular Buy
The business has seen sales in China collapse. And concern about the long-term effect that the corruption case will have on future revenue growth has weighed heavily on GlaxoSmithKline for many months now. So news last month that the case had been ...
Related articles »  
GlaxoSmithKline plc Is Becoming More Attractive By The Day
GlaxoSmithKline plc's (LSE: GSK) share price is falling again today, which is great news, as at these prices the company is a steal.
Related articles »  
Why Have GlaxoSmithKline plc And AstraZeneca plc Followed The FTSE 100 ...
Investors tend to turn to big blue-chip dividend payers at times of market volatility, and in times past the steady earnings of pharma giants GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN) have been a particular source of comfort when the market ...
GlaxoSmithKline plc Receives �Sell� Rating from Liberum Capital (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its �sell� rating restated by analysts at Liberum Capital in a research report issued to clients and investors on Friday.
GlaxoSmithKline plc's "Neutral" Rating Reiterated at JPMorgan ...  Ticker Report
GlaxoSmithKline plc Rating Reiterated by Credit Suisse (GSK)  Watch List News (press release)
Related articles »  
This May Be Your Last Chance To Buy Diageo plc, GlaxoSmithKline plc And ...
There's no denying that Diageo (LSE: DGE) has underperformed this year. Concerns about the company's growth have spooked investors and sales within China have been hit hard by the government's anti-extravagance measures.
Related articles »  
Stock Update: GlaxoSmithKline plc (ADR) (NYSE:GSK)
[Bloomberg] GlaxoSmithKline plc (ADR) (NYSE:GSK) is exploring an initial public offering for its Viiv Healthcare Ltd. subsidiary to capitalize on the unit's soaring sales of HIV drugs even as revenue for the parent company declines.
GlaxoSmithKline plc Lifted to �Overweight� at Barclays (GSK)  Watch List News (press release)
GlaxoSmithKline plc Stock Rating Upgraded by Barclays (GSK)  Intercooler
Related articles »  
GlaxoSmithKline plc Stock Rating Reaffirmed by Zacks (GSK)
Zacks reaffirmed their underperform rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a research note issued to investors on Tuesday.
What Management Would Prefer You Didn't Know About GlaxoSmithKline plc
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has unfortunately gone one step too far on a number of occasions. The actions of its representatives in China have been put under the spotlight, and now more allegations are emerging from the Middle East.
Morning Buzz: GlaxoSmithKline plc (ADR) (NYSE:GSK), Sunedison Inc (NYSE ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) reported Q3 earnings in which sales fell 10% but EPS exceeded estimates, and announced a cost savings plan, as revenues from its flagship respiratory drug Advair continued an extended decline.
Related articles »